Nucala is the first biologic approved in the US for six to 11-year-old children with severe eosinophilic asthma Read more
Roxadustat approved in China for the treatment of anaemia in non-dialysis-dependent patients with CKD Read more
Lynparza Phase III PAOLA-1 trial met primary endpoint as 1st-line maintenance treatment with bevacizumab for advanced ovarian cancer Read more
Boehringer and MD Anderson form unique Virtual Research and Development Center to rapidly advance new cancer therapies Read more
Takeda Submits NDA for a Subcutaneous Formulation of Vedolizumab for Patients with Moderately to Severely Active Ulcerative Colitis in Japan Read more
Pfizer Announces Closing of Joint Venture With GlaxoSmithKline to Create a Premier Global Consumer Healthcare Company Read more